TEVA E2 Pill - white round, 8mm
Pill with imprint TEVA E2 is White, Round and has been identified as Erlotinib Hydrochloride 25 mg. It is supplied by Teva Pharmaceuticals USA, Inc.
Erlotinib is used in the treatment of Pancreatic Cancer; Non Small Cell Lung Cancer and belongs to the drug class EGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Erlotinib 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TEVA E2
Erlotinib Hydrochloride
- Imprint
- TEVA E2
- Strength
- 25 mg
- Color
- White
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- EGFR inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA, Inc.
- National Drug Code (NDC)
- 00093-7662
- Inactive Ingredients
-
silicon dioxide,
hypromellose 2910 (3 mPa.s),
hypromellose 2910 (6 mPa.s),
hypromellose 2910 (50 mPa.s),
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
polydextrose,
polyethylene glycol 8000,
sodium lauryl sulfate,
sodium starch glycolate type A potato,
titanium dioxide,
triacetin
Note: Inactive ingredients may vary.
Related images for "TEVA E2"
More about erlotinib
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (45)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: EGFR inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
